This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Feb;13(1):27.

doi: 10.1136/ebmh.13.1.27.

Review: buprenorphine better than alpha2 adrenergic agonists for managing opioid withdrawal

John Mendelson¹

Affiliations

PMID: 20164524
DOI: 10.1136/ebmh.13.1.27

Comment

Review: buprenorphine better than alpha2 adrenergic agonists for managing opioid withdrawal

John Mendelson. Evid Based Ment Health. 2010 Feb.

. 2010 Feb;13(1):27.

doi: 10.1136/ebmh.13.1.27.

Author

John Mendelson¹

Affiliation

¹ California Pacific Medical Center Research Institute, San Francisco, California, USA.

PMID: 20164524
DOI: 10.1136/ebmh.13.1.27

No abstract available

PubMed Disclaimer

Comment on

Buprenorphine for the management of opioid withdrawal.
Gowing L, Ali R, White JM. Gowing L, et al. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD002025. doi: 10.1002/14651858.CD002025.pub4. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2017 Feb 21;2:CD002025. doi: 10.1002/14651858.CD002025.pub5. PMID: 19588330 Updated.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.